We are live on
!
Find out more
Point72 Asset Management Portfolio holdings
AUM
$78.1B
1-Year Est. Return
55.25%
This Fund
S&P 500
This Quarter
Est. Return
+13.17%
1 Year Est. Return
+55.25%
3 Year Est. Return
+151.79%
5 Year Est. Return
+188.05%
10 Year Est. Return
+800.63%
AUM
$33.6B
AUM Growth
+$1.34B
(+4.1%)
Cap. Flow
-$1.43B
Cap. Flow
% of AUM
-4.24%
Top 10 Holdings %
Top 10 Hldgs %
13.71%
Holding
2,962
New
772
Increased
492
Reduced
601
Closed
858
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$431M |
| 2 |
NVIDIA
NVDA
|
+$220M |
| 3 |
Micron Technology
MU
|
+$182M |
| 4 |
Union Pacific
UNP
|
+$168M |
| 5 |
Southern Company
SO
|
+$162M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$459M |
| 2 |
Meta Platforms (Facebook)
META
|
+$403M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$380M |
| 4 |
Salesforce
CRM
|
+$271M |
| 5 |
Intel
INTC
|
+$271M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.23% |
| 2 | Technology | 16.9% |
| 3 | Consumer Discretionary | 11.34% |
| 4 | Industrials | 9.64% |
| 5 | Energy | 5.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Builders FirstSource
BLDR
$7.15B
| $1.72M | 0.01% |
12,641
-165,730
| -93% | -$18.4M |
|
1027
CALL
Vir Biotechnology
VIR
$1.46B
| $1.71M | 0.01% |
+69,900
| New | +$1.76M |
|
1028
CALL
ICICI Bank
IBN
$108B
| $1.7M | 0.01% |
73,500
| – | – |
|
1029
Under Armour Class C
UA
$2.77B
| $1.65M | ﹤0.01% |
245,550
-276,150
| -53% | -$2.03M |
|
1030
CALL
HCA Healthcare
HCA
$87.2B
| $1.64M | ﹤0.01% |
5,400
+800
| +17% | +$222K |
|
1031
CALL
Wabtec
WAB
$49.1B
| $1.63M | ﹤0.01% |
+14,900
| New | +$1.48M |
|
|
MOR
1032
DELISTED
MorphoSys AG American Depositary Shares
MOR
| $1.63M | ﹤0.01% |
+218,700
| New | +$1.33M |
|
1033
CALL
Five Below
FIVE
$12B
| $1.63M | ﹤0.01% |
+8,300
| New | +$1.62M |
|
1034
PUT
Wayfair
W
$11.2B
| $1.63M | ﹤0.01% |
25,000
-72,500
| -74% | -$3.05M |
|
1035
BioXcel Therapeutics
BTAI
$24.9M
| $1.61M | ﹤0.01% |
+15,122
| New | +$5.04M |
|
1036
Celestica
CLS
$38.1B
| $1.61M | ﹤0.01% |
+110,900
| New | +$1.37M |
|
|
ITCI
1037
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $1.59M | ﹤0.01% |
25,121
-209,008
| -89% | -$13M |
|
1038
Apollo Global Management
APO
$72.4B
| $1.58M | ﹤0.01% |
20,550
-718,850
| -97% | -$48.1M |
|
|
NOTV
1039
CALL
DELISTED
Inotiv
NOTV
| $1.57M | ﹤0.01% |
+329,200
| New | +$1.82M |
|
|
DAWN
1040
DELISTED
Day One Biopharmaceuticals
DAWN
| $1.56M | ﹤0.01% |
+131,000
| New | +$1.71M |
|
1041
PUT
CSX Corp
CSX
$93.4B
| $1.54M | ﹤0.01% |
45,300
+30,000
| +196% | +$949K |
|
1042
Alphatec Holdings
ATEC
$1.46B
| $1.54M | ﹤0.01% |
85,571
-518,080
| -86% | -$8.07M |
|
|
FUSN
1043
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $1.54M | ﹤0.01% |
328,868
| – | – |
|
1044
State Street SPDR S&P Regional Banking ETF
KRE
$4.5B
| $1.54M | ﹤0.01% |
37,600
-66,444
| -64% | -$2.73M |
|
1045
CALL
T-Mobile US
TMUS
$185B
| $1.53M | ﹤0.01% |
11,000
-3,500
| -24% | -$491K |
|
1046
Guidewire Software
GWRE
$12.6B
| $1.51M | ﹤0.01% |
19,800
-29,900
| -60% | -$2.29M |
|
|
PGTI
1047
PUT
DELISTED
PGT, Inc.
PGTI
| $1.46M | ﹤0.01% |
+50,000
| New | +$1.32M |
|
1048
Montauk Renewables
MNTK
$243M
| $1.45M | ﹤0.01% |
194,854
+192,103
| +6,983% | +$1.32M |
|
|
CDTX
1049
DELISTED
Cidara Therapeutics
CDTX
| $1.41M | ﹤0.01% |
62,500
| – | – |
|
1050
PUT
SLB Ltd
SLB
$73.6B
| $1.4M | ﹤0.01% |
28,600
| – | – |
|
Similar funds
CBU
BC
Point72 Asset Management's Q2 2023 Portfolio in Review
As of Q2 2023, Point72 Asset Management held 2,962 positions worth $33.6B, up 4.1% from $32.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Point72 Asset Management withdrew a net $1.43B in Q2 2023, closing 858 positions and reducing 601 holdings. Its most notable exit was Prometheus Biosciences, Inc. Common Stock, an estimated $157M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Point72 Asset Management opened a new position in Micron Technology worth $178M.
- Point72 Asset Management's largest Q2 2023 buy was Micron Technology: 2,825,000 shares worth $178M.
- Point72 Asset Management added most to Microsoft in Q2 2023, an estimated $431M increase.
- Point72 Asset Management's biggest Q2 2023 reduction was Broadcom, cutting an estimated $459M.
- Point72 Asset Management fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $157M.
- Point72 Asset Management's ten largest holdings make up 14% of its $33.6B portfolio in Q2 2023.
- Point72 Asset Management opened 772 new positions and closed 858 in Q2 2023.
- Point72 Asset Management's portfolio value rose 4.1% quarter-over-quarter to $33.6B.
Based on Point72 Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.